McMillan Shakespeare Limited
McMillan Shakespeare Limited Fundamental Analysis
McMillan Shakespeare Limited (MMS.AX) shows moderate financial fundamentals with a PE ratio of 12.94, profit margin of 17.77%, and ROE of 88.28%. The company generates $0.6B in annual revenue with weak year-over-year growth of -16.39%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 21.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze MMS.AX's fundamental strength across five key dimensions:
Efficiency Score
WeakMMS.AX struggles to generate sufficient returns from assets.
Valuation Score
ExcellentMMS.AX trades at attractive valuation levels.
Growth Score
ModerateMMS.AX shows steady but slowing expansion.
Financial Health Score
ModerateMMS.AX shows balanced financial health with some risks.
Profitability Score
ModerateMMS.AX maintains healthy but balanced margins.
Key Financial Metrics
Is MMS.AX Expensive or Cheap?
P/E Ratio
MMS.AX trades at 12.94 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, MMS.AX's PEG of 1.41 indicates fair valuation.
Price to Book
The market values McMillan Shakespeare Limited at 11.43 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 4.07 times EBITDA. This is generally considered low.
How Well Does MMS.AX Make Money?
Net Profit Margin
For every $100 in sales, McMillan Shakespeare Limited keeps $17.77 as profit after all expenses.
Operating Margin
Core operations generate -2.02 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $88.28 in profit for every $100 of shareholder equity.
ROA
McMillan Shakespeare Limited generates $6.35 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
McMillan Shakespeare Limited generates limited operating cash flow of $-45.87M, signaling weaker underlying cash strength.
Free Cash Flow
McMillan Shakespeare Limited generates weak or negative free cash flow of $-57.02M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.82 in free cash annually.
FCF Yield
MMS.AX converts -4.43% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
12.94
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
1.41
vs 25 benchmark
P/B Ratio
Price to book value ratio
11.43
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.30
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
7.57
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.13
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.88
vs 25 benchmark
ROA
Return on assets percentage
0.06
vs 25 benchmark
ROCE
Return on capital employed
-0.01
vs 25 benchmark
How MMS.AX Stacks Against Its Sector Peers
| Metric | MMS.AX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 12.94 | 26.04 | Better (Cheaper) |
| ROE | 88.28% | 1287.00% | Weak |
| Net Margin | 17.77% | -33418.00% (disorted) | Strong |
| Debt/Equity | 7.57 | 0.75 | Weak (High Leverage) |
| Current Ratio | 1.13 | 10.38 | Neutral |
| ROA | 6.35% | -1484956.00% (disorted) | Weak |
MMS.AX outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews McMillan Shakespeare Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
0.14%
Industry Style: Cyclical, Value, Infrastructure
GrowingEPS CAGR
8416.22%
Industry Style: Cyclical, Value, Infrastructure
High GrowthFCF CAGR
-135.91%
Industry Style: Cyclical, Value, Infrastructure
Declining